Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “GE Junction Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 15 of 0 results

Testing effectiveness (Phase 2)Active Not RecruitingNCT01142388
What this trial is testing

Paclitaxel With or Without Cixutumumab as Second-Line Therapy in Treating Patients With Metastatic Esophageal Cancer or Gastroesophageal Junction Cancer

Who this might be right for
Metastatic Esophageal AdenocarcinomaMetastatic Esophageal Squamous Cell CarcinomaMetastatic Gastroesophageal Junction Adenocarcinoma+5 more
National Cancer Institute (NCI) 94
Testing effectiveness (Phase 2)Ended earlyNCT00256269
What this trial is testing

Oxaliplatin and Irinotecan in Recurrent or Metastatic Esophageal and Gastroesophageal (GE) Junction Carcinoma

Who this might be right for
Esophageal CancerGastroesophageal Cancer
University of California, Irvine 4
Testing effectiveness (Phase 2)Looking for participantsNCT07165847
What this trial is testing

Neoadjuvant Radiotherapy Plus Tegafur, Oxaliplatin and Iparomlimab and Tuvonralimab in Resectable Gastric and GE-junction Cancer : A Randomized, Two-arm, Prospective Trial (TRIUNITE-05)

Who this might be right for
ImmunotherapyGastric Cancer (GC)Radiotherapy+2 more
Daping Hospital and the Research Institute of Surgery of the Third Military Medical University 40
Testing effectiveness (Phase 2)UnknownNCT04119622
What this trial is testing

Toripalimab Combined With Chemotherapy as Neoadjuvant Treatment of Gastric Cancer

Who this might be right for
Gastric Cancer Stage IIGastric Cancer Stage III
Aiping Zhou 30
Not applicableWithdrawnNCT01031056
What this trial is testing

Collection of Biospecimen & Clinical Information in Patients w/ Gastrointestinal Cancers

Who this might be right for
Gastrointestinal NeoplasmsGynecologic CancersGynecologic Cancers Cervical Cancer+11 more
Stanford University
Large-scale testing (Phase 3)Study completedNCT00680901
What this trial is testing

LOGiC - Lapatinib Optimization Study in ErbB2 (HER2) Positive Gastric Cancer: A Phase III Global, Blinded Study Designed to Evaluate Clinical Endpoints and Safety of Chemotherapy Plus Lapatinib

Who this might be right for
Neoplasms, Gastrointestinal Tract
Novartis Pharmaceuticals 545
Not applicableWithdrawnNCT05067842
What this trial is testing

Circulating Tumor DNA (ctDNA) in Locally Advanced Esophageal and Gastroesophageal (GE) Junction Adenocarcinoma

Who this might be right for
Adenocarcinoma Esophagus
Medical College of Wisconsin
Testing effectiveness (Phase 2)Study completedNCT01611857
What this trial is testing

Phase I/II Trial of Tivantinib With FOLFOX for the Treatment of Advanced Solid Tumors and Previously Untreated Metastatic Adenocarcinoma of the Distal Esophagus, Gastroesophageal Junction or Stomach

Who this might be right for
Malignant Solid TumourGastroesophageal Cancer
SCRI Development Innovations, LLC 49
Testing effectiveness (Phase 2)Ended earlyNCT00561197
What this trial is testing

An Open-label, Single-center, Phase 1/ 2 Study of Chemoradiotherapy and AT-101 in Patients With Locally Advanced Esophageal or Gastroesophageal Junction Cancer

Who this might be right for
Locally Advanced Esophageal or GE Junction Cancer
Ascenta Therapeutics 13
Testing effectiveness (Phase 2)Study completedNCT00165191
What this trial is testing

Doxorubicin, Cisplatin, 5-Fluorouracil in Patients With Advanced Adenocarcinoma of the Stomach or Esophagus

Who this might be right for
Adenocarcinoma of StomachAdenocarcinoma of GE JunctionAdenocarcinoma of Esophagus
Dana-Farber Cancer Institute 32
Not applicableStudy completedNCT01824966
What this trial is testing

Signet Ring Cell Carcinoma in Esophageal Adenocarcinoma

Who this might be right for
AdenocarcinomaEsophageal Cancer
University Hospital, Gasthuisberg 82
Testing effectiveness (Phase 2)Study completedNCT00526669
What this trial is testing

Study For Patients With Untreated Gastric Cancer Who Will Receive Capecitabine And Lapatinib

Who this might be right for
Neoplasms, Gastrointestinal Tract
GlaxoSmithKline 68
Not applicableStudy completedNCT02538562
What this trial is testing

Human Epidermal Growth Factor Receptor 2 (HER2) Advanced Gastric Epidemiology Study in Korea

Who this might be right for
Gastric CancerGastroesophageal Junction Cancer
Hoffmann-La Roche 1,695
Early research (Phase 1)Study completedNCT01183559
What this trial is testing

A Trial of ZD6474, Paclitaxel, Carboplatin, 5-Fluorouracil, and Radiation Therapy Followed by Surgery

Who this might be right for
Cancer of the EsophagusAdenocarcinoma of the Gastroesophageal JunctionCancer of the Stomach
Fox Chase Cancer Center 9
Testing effectiveness (Phase 2)Study completedNCT00319735
What this trial is testing

Cetuximab and Radiation Therapy for Surgically Resectable Esophageal and Gastroesophageal (GE) Junction Carcinomas

Who this might be right for
Esophageal Cancer
Nasser Hanna, M.D. 41